- Home
- PMN vs CING Comparison
PMN vs CING Comparison
Compare PMN & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMN
- CING
- Stock Information
- Founded
- PMN 2004
- CING 2012
- Country
- PMN Canada
- CING United States
- Employees
- PMN N/A
- CING N/A
- Industry
- PMN Pharmaceuticals and Biotechnology
- CING Biotechnology: Pharmaceutical Preparations
- Sector
- PMN Health Care
- CING Health Care
- Exchange
- PMN Nasdaq
- CING Nasdaq
- Market Cap
- PMN 23.5M
- CING 21.6M
- IPO Year
- PMN N/A
- CING 2021
- Fundamental
- Price
- PMN $0.42
- CING $3.56
- Analyst Decision
- PMN Strong Buy
- CING Strong Buy
- Analyst Count
- PMN 3
- CING 4
- Target Price
- PMN $4.33
- CING $33.00
- AVG Volume (30 Days)
- PMN 819.9K
- CING 258.1K
- Earning Date
- PMN 11-13-2025
- CING 11-07-2025
- Dividend Yield
- PMN N/A
- CING N/A
- EPS Growth
- PMN N/A
- CING N/A
- EPS
- PMN N/A
- CING N/A
- Revenue
- PMN N/A
- CING N/A
- Revenue This Year
- PMN N/A
- CING N/A
- Revenue Next Year
- PMN N/A
- CING N/A
- P/E Ratio
- PMN N/A
- CING N/A
- Revenue Growth
- PMN N/A
- CING N/A
- 52 Week Low
- PMN $0.38
- CING $3.02
- 52 Week High
- PMN $1.59
- CING $6.01
- Technical
- Relative Strength Index (RSI)
- PMN 41.57
- CING 40.95
- Support Level
- PMN $0.41
- CING $3.55
- Resistance Level
- PMN $0.48
- CING $4.04
- Average True Range (ATR)
- PMN 0.04
- CING 0.29
- MACD
- PMN -0.00
- CING -0.03
- Stochastic Oscillator
- PMN 5.00
- CING 4.00
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.